Maximize Analytical Capabilities, Enable Researchers to Advance Discovery in Cancer, Other Complex Diseases.

At Connectikpeople.co soon RetinkNow®, we love collaborative research and development, because this approach stimulates the performance and competiveness. Today, we are thrilled to observe that, Agilent Technologies and PREMIER Biosoft couple Hardware-Software platforms to advance Glycomics research. 

As part of our global commitment, we recalls that, Glycomics ,is the study of glycome structures (sugars, modified sugars and saccharides) in molecules and organisms. It isalso billed as a tangled web of carbohydrates, proteins and lipids that modulate cellular function and play a primary role in the development of cancer, bacterial and viral diseases, and glycan-specific hereditary diseases. 

Henceforth, a selection of Agilent’s high-resolution mass spectrometry and liquid chromatography instruments supports PREMIER Biosoft’s SimGlycansoftware. The combined analytical strength of Agilent instrumentation and PREMIER Biosoft’s glycan and glycopeptide data analysis software , aim to open up a new level of discovery for researchers studying the biology of disease. Biopharmaceutical research

and development laboratories can now harness this partnership.